Global Stem Cells provides an extensive treatment protocol for Chronic Kidney Disease (CKD) which utilises higher quantities of stem cells, extensive rehabilitation, and many supportive therapies and supplements. This effective combination of the most advanced medical technologies with functional medicine has helped patients achieve significant improvements.
About Chronic Kidney Disease, the traditional treatments, and how Stem Cell Therapy can help
Chronic Kidney Disease (CKD) is a leading cause of morbidity and mortality that is estimated to be affecting about 11% of the adult population. It can progress to end stage renal failure that has no cure and requires renal replacement therapy, that is, dialysis or kidney transplant. Many different factors and conditions can cause CKD including hypertension, diabetes, glomerulonephritis, polycystic kidney disease and lupus. The major symptoms include lack of appetite, tiredness, lack of concentration, fluid retention (edema), and dry and itchy skin. Removing the underlying cause and offering early treatment may prevent the progression to end stage renal failure, but despite all this, many patients keep progressing and often require dialysis or renal transplant as a last treatment option.
With the increasing rate of chronic kidney disease, the scientific community has urged the need for stem cell treatment. Extensive research has been done on mesenchymal stem cells due to their ability to differentiate into many different stem cell types. These cells are readily available in various body tissues and can be extracted and purified without any risk to the donor. These cells are also proven very safe in allogenic transplantations as they do not cause rejection or graft-versus-host-disease (GVHD). These cells can integrate into renal tubular cells and can differentiate into mesengial cells. Moreover, these cells stimulate the kidney’s own stem cells (resident stem cells) and release growth factors which promote the survival of renal cells, thus, initiating a natural recovery.
Global Stem Cells utilizes mesenchymal stem cells in treating patients with CKD and renal failure and have successfully treated patients with good treatment outcomes. The improvements we have seen in our patients include improved renal function and its associated symptoms, and slowing down of the disease progression.
5 day personalised protocol to include the following treatments and services
4 (four) allogenic MSC packets40 million MSC each
Total minimum of 160 million MSC (all through IV)
Standard AccommodationPatient Meals
Safety of Treatments
In addition to extensive case histories based collectively on over 10,000 patients treated with Mesenchymal Stem Cells, numerous clinical studies have shown the treatment to be safe. E.g.
“Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions, Journal of Translational Medicine 2010, 8:75 doi:10.1186/1479-5876-8-75, Wan-Zhang Yang et al.”
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7(10):e47559.Lalu M.M et Al